SCHEMBL26548544

SCHEMBL26548544

C[Si](C)(C)c1ccc(-c2ccc(-c3ccc4cc(-c5ccc(-c6ccc([Si](C)(C)C)cc6)cc5)ccc4c3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.44
ESR2 Q92731 5/20 0.44
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
HSD17B1 P14061 2/20 0.39
HSD17B2 P37059 2/20 0.39
CYP11B1 P15538 4/20 0.38
CYP11B2 P19099 4/20 0.38
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 3/20 0.37
CYP2C9 P11712 3/20 0.37
CYP17A1 P05093 3/20 0.37
SCN5A Q14524 1/20 0.37
ABL1 P00519 1/20 0.37
ABCB1 P08183 1/20 0.37
BCR P11274 1/20 0.37
CYP19A1 P11511 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548158 1.00 ESR1 (0.44) ESR1ESR2LPLLIPGHSD17B1
SCHEMBL26548674 0.93 ESR1 (0.46) ESR1ESR2LPLLIPGCYP11B1
SCHEMBL26549019 0.93 ESR1 (0.46) ESR1ESR2LPLLIPGCYP11B1
SCHEMBL26820142 0.91 ESR1 (0.55) ESR1ESR2LPLLIPGHSD17B1
SCHEMBL26547927 0.91 ESR1 (0.55) ESR1ESR2LPLLIPGHSD17B1
SCHEMBL26820135 0.91 ESR1 (0.55) ESR1ESR2LPLLIPGHSD17B1
SCHEMBL26548377 0.91 ESR1 (0.55) ESR1ESR2LPLLIPGHSD17B1
SCHEMBL13063101 0.91 ESR1 (0.55) ESR1ESR2LPLLIPGHSD17B1
SCHEMBL26566383 0.91 CYP1A2 (0.47) ESR1ESR2CYP1A2CYP3A4CYP2C9
SCHEMBL26820143 0.91 ESR1 (0.55) ESR1ESR2LPLLIPGHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 ESR1 940/4885ESR2 1164/4885LPL 2737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.